Get the Stockscreener App
0.4522
2.75%
-0.0128
After Hours:
.45
-0.0022
-0.49%
Theriva Biologics Inc Stock (TOVX) Forecast
The Theriva Biologics Inc (TOVX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.5129, representing a +13.43% increase from the current price of $0.4522. The highest analyst price target is $0.6079, and the lowest is $0.4179.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TOVX Price Target
Average 0.4834
(+6.91% Upside)
Is Theriva Biologics Inc (TOVX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.81 | Neutral |
| STOCH(9,6) | 43.79 | Neutral |
| STOCHRSI(14) | 53.43 | Neutral |
| MACD(12,26) | -0.0842 | Buy |
| ADX(14) | 34.88 | Sell |
| William %R | -68.15 | Neutral |
| CCI(14) | -49.32 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4819
Sell
|
0.4793
Sell
|
| MA20 |
0.4696
Sell
|
0.5242
Sell
|
| MA50 |
0.8336
Sell
|
0.7832
Sell
|
| MA100 |
1.0804
Sell
|
4.1557
Sell
|
| MA200 |
1.4921
Sell
|
37.49
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TOVX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on TOVX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.81 indicates that TOVX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 43.79 indicates that TOVX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 53.43 indicates that TOVX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.88 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -49.32 indicates that TOVX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TOVX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Theriva Biologics Inc financial reports and earnings history, Theriva Biologics Inc (TOVX) stock could reach $0.5588 by 2030, $0.4864 by 2040 and $0.414 by 2050. See the projected annual prices until 2050 of the Theriva Biologics Inc stock below:
- Theriva Biologics Inc (TOVX) is expected to reach an average price of $0.3397 in 2035, with a high prediction of $0.5226 and a low estimate of $0.3296. This indicates an $-24.89% rise from the last recorded price of $0.4522.
- Theriva Biologics Inc (TOVX) stock is projected to chart a bullish course in 2040, with an average price target of $0.3331, representing an $-26.34% surge from its current level. The forecast ranges from a conservative $0.2934 to a sky-high $0.4864.
- Our analysts predict Theriva Biologics Inc (TOVX) to jump -34.34% by 2045, soaring from $0.2573 to an average price of $0.2969, potentially reaching $0.4502. While $0.2573 is the low estimate, the potential upside is significant.
- Theriva Biologics Inc (TOVX) stock is expected to climb by 2050, reaching an average of $0.2608, a $-42.34% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.414 and $0.2211, respectively, highlighting the market's uncertainty.
Theriva Biologics Inc Stock (TOVX) Year by Year Forecast
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2025
Theriva Biologics Inc Stock (TOVX) is expected to reach an average price of $0.4875 in 2025, with a high prediction of $0.6765 and a low estimate of $0.2984. This indicates an +7.80% rise from the last recorded price of $0.4522.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $0.4254 | $0.4179 | $0.6079 | -5.92% |
| August, 2025 | $0.4028 | $0.393 | $0.4729 | -10.93% |
| September, 2025 | $0.513 | $0.3892 | $0.538 | +13.44% |
| October, 2025 | $0.458 | $0.438 | $0.5344 | +1.28% |
| November, 2025 | $0.436 | $0.398 | $0.6725 | -3.58% |
| December, 2025 | $0.3845 | $0.321 | $0.448 | -14.97% |
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2026
The predicted value for Theriva Biologics Inc (TOVX) in 2026 is set at an average of $0.4794. Estimates vary from a peak of $0.6685 to a trough of $0.2904, indicating an +6.02% surge from the present price of $0.4522.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.5839 | $0.2944 | $0.5839 | +29.12% |
| February, 2026 | $0.414 | $0.3939 | $0.6039 | -8.44% |
| March, 2026 | $0.4184 | $0.3851 | $0.4939 | -7.46% |
| April, 2026 | $0.449 | $0.4039 | $0.534 | -0.71% |
| May, 2026 | $0.404 | $0.394 | $0.484 | -10.66% |
| June, 2026 | $0.4335 | $0.404 | $0.6685 | -4.13% |
| July, 2026 | $0.39 | $0.2904 | $0.434 | -13.76% |
| August, 2026 | $0.5299 | $0.3809 | $0.5999 | +17.18% |
| September, 2026 | $0.3999 | $0.3899 | $0.5829 | -11.56% |
| October, 2026 | $0.4899 | $0.3811 | $0.5099 | +8.35% |
| November, 2026 | $0.445 | $0.43 | $0.53 | -1.60% |
| December, 2026 | $0.449 | $0.39 | $0.6645 | -0.71% |
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Theriva Biologics Inc (TOVX) is $0.4714, with a high forecast of $0.6605 and a low forecast of $0.2823. This indicates an +4.25% increase from the last price of $0.4522.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3995 | $0.313 | $0.45 | -11.65% |
| February, 2027 | $0.5138 | $0.2863 | $0.5158 | +13.63% |
| March, 2027 | $0.4134 | $0.4059 | $0.5959 | -8.59% |
| April, 2027 | $0.3907 | $0.3809 | $0.4609 | -13.60% |
| May, 2027 | $0.5009 | $0.3771 | $0.5259 | +10.78% |
| June, 2027 | $0.446 | $0.426 | $0.5223 | -1.38% |
| July, 2027 | $0.424 | $0.386 | $0.6605 | -6.23% |
| August, 2027 | $0.3785 | $0.309 | $0.436 | -16.29% |
| September, 2027 | $0.5718 | $0.2823 | $0.5718 | +26.45% |
| October, 2027 | $0.402 | $0.3819 | $0.5918 | -11.11% |
| November, 2027 | $0.4064 | $0.3731 | $0.4819 | -10.13% |
| December, 2027 | $0.4369 | $0.3919 | $0.5219 | -3.37% |
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2028
In 2028, Theriva Biologics Inc (TOVX) is projected to reach an average price of $0.4654, with a high projection of $0.6565 and a low estimate of $0.2742. This indicates an +2.91% rise from the last price of $0.4522.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.392 | $0.382 | $0.472 | -13.32% |
| February, 2028 | $0.4215 | $0.392 | $0.6565 | -6.78% |
| March, 2028 | $0.3779 | $0.2783 | $0.422 | -16.44% |
| April, 2028 | $0.5178 | $0.3688 | $0.5878 | +14.51% |
| May, 2028 | $0.3879 | $0.3778 | $0.5708 | -14.23% |
| June, 2028 | $0.4779 | $0.3691 | $0.4979 | +5.69% |
| July, 2028 | $0.433 | $0.418 | $0.5179 | -4.26% |
| August, 2028 | $0.437 | $0.378 | $0.6525 | -3.36% |
| September, 2028 | $0.3876 | $0.3011 | $0.438 | -14.30% |
| October, 2028 | $0.5018 | $0.2742 | $0.5038 | +10.96% |
| November, 2028 | $0.4013 | $0.3938 | $0.5838 | -11.25% |
| December, 2028 | $0.3787 | $0.3689 | $0.4488 | -16.26% |
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2029
The 2029 price forecast for Theriva Biologics Inc Stock (TOVX) is $0.4573 on average, with a high prediction of $0.6485 and a low estimate of $0.2662. This represents an +1.14% increase from the previous price of $0.4522.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4339 | $0.3651 | $0.5139 | -4.04% |
| February, 2029 | $0.434 | $0.4139 | $0.462 | -4.03% |
| March, 2029 | $0.412 | $0.374 | $0.6485 | -8.89% |
| April, 2029 | $0.3666 | $0.2971 | $0.424 | -18.94% |
| May, 2029 | $0.5598 | $0.2702 | $0.5598 | +23.78% |
| June, 2029 | $0.3899 | $0.3698 | $0.5798 | -13.78% |
| July, 2029 | $0.3944 | $0.3611 | $0.4699 | -12.79% |
| August, 2029 | $0.4249 | $0.3799 | $0.5099 | -6.03% |
| September, 2029 | $0.38 | $0.37 | $0.46 | -15.97% |
| October, 2029 | $0.3753 | $0.3712 | $0.6445 | -17.02% |
| November, 2029 | $0.3658 | $0.2662 | $0.4057 | -19.11% |
| December, 2029 | $0.5057 | $0.3567 | $0.5757 | +11.84% |
Theriva Biologics Inc Stock (TOVX) Price Forecast for 2030
Theriva Biologics Inc Stock (TOVX) is expected to reach an average price of $0.4513 in 2030, with a high forecast of $0.6405 and a low forecast of $0.2622. This signifies an -0.19% decrease from the last price of $0.4522.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3758 | $0.3658 | $0.5588 | -16.89% |
| February, 2030 | $0.4659 | $0.357 | $0.4859 | +3.02% |
| March, 2030 | $0.4209 | $0.4059 | $0.5059 | -6.91% |
| April, 2030 | $0.476 | $0.366 | $0.6405 | +5.26% |
| May, 2030 | $0.3756 | $0.2891 | $0.5006 | -16.95% |
| June, 2030 | $0.4897 | $0.2622 | $0.4917 | +8.29% |
| July, 2030 | $0.3893 | $0.3818 | $0.5717 | -13.92% |
| August, 2030 | $0.3666 | $0.3568 | $0.4368 | -18.93% |
| September, 2030 | $0.4769 | $0.353 | $0.5019 | +5.46% |
| October, 2030 | $0.422 | $0.4019 | $0.4983 | -6.69% |
| November, 2030 | $0.40 | $0.362 | $0.6365 | -11.54% |
| December, 2030 | $0.3546 | $0.2851 | $0.412 | -21.58% |
2.32%
0.98%
Cap:
|
Volume (24h):